EW
Edwards Lifesciences Corp
87.20$
+2.4%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1.8% | +5.0% | +4.2% | -2.3% | +2.3% | +1.9% | +8.5% | +1.4% | +1.1% | +5.0% | +5.6% | – | |
| – | -7.8% | +15.3% | +2.9% | -11.7% | +11.1% | +3.2% | +13.6% | +0.8% | -1.3% | +5.5% | +8.7% | – | |
| – | +4.6% | +2.5% | +4.6% | +0.3% | +0.2% | +1.6% | +7.1% | +1.7% | +1.6% | +4.9% | +4.7% | – | |
| – | -0.3% | +6.0% | +6.2% | -7.0% | +7.0% | -6.1% | +8.5% | +1.6% | -4.6% | -1.6% | +5.9% | – | |
| – | +8.9% | +2.3% | -7.9% | -6.5% | +16.7% | -5.3% | +7.8% | +2.5% | +17.2% | -13.4% | +7.5% | – | |
| – | +5.4% | +4.0% | +5.6% | +2.4% | +5.4% | -8.3% | +5.9% | +3.4% | +9.5% | -9.8% | +7.3% | – | |
| – | +2.9% | -0.3% | +2.6% | -3.9% | -10.8% | +26.3% | +9.1% | -1.3% | -12.9% | +39.0% | +0.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -5.3% | +1.1% | +4.1% | +4.2% | -3.2% | +11.2% | -7.8% | -12.9% | -74.1% | +407.7% | +13.2% | – | |
| – | -35.3% | +35.8% | -56.4% | +101.5% | +10.8% | +55.9% | -8.5% | -12.8% | -53.3% | +198.9% | +255.6% | – | |
| – | -3.9% | -4.9% | +3.4% | +744.3% | -87.4% | -7.2% | -7.9% | -11.7% | -68.7% | +317.4% | -36.5% | – | |
| – | -4.9% | +1.4% | +4.0% | +0.6% | +12.8% | -2.7% | -14.9% | -3.1% | -65.7% | +275.6% | +3.9% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.